TY - JOUR
T1 - The cost effectiveness of psychological and pharmacological interventions for social anxiety disorder
T2 - A model-based economic analysis
AU - Mavranezouli, Ifigeneia
AU - Mayo-Wilson, Evan
AU - Dias, Sofia
AU - Kew, Kayleigh
AU - Clark, David M.
AU - Ades, A. E.
AU - Pilling, Stephen
N1 - Funding Information:
The authors have read the journal's policy and the authors of this manuscript have the following competing interests: IM, EMW, KK and SP received support from the National Collaborating Centre for Mental Health, which was in receipt of funding from the National Institute for Health and Care Excellence (NICE), for the submitted work. SD and AEA received support from the NICE Clinical Guidelines Technical Support Unit, University of Bristol, with funding from the Centre for Clinical Practice (NICE). DMC is the developer of one of the versions of individual CBT under consideration (Cognitive Therapy following the Clark & Wells manual). The authors report no other relationships or activities that could appear to have influenced the submitted work.
Publisher Copyright:
© 2015 Mavranezouli et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
PY - 2015/10/27
Y1 - 2015/10/27
N2 - Background: Social anxiety disorder is one of the most persistent and common anxiety disorders. Individually delivered psychological therapies are the most effective treatment options for adults with social anxiety disorder, but they are associated with high intervention costs. Therefore, the objective of this study was to assess the relative cost effectiveness of a variety of psychological and pharmacological interventions for adults with social anxiety disorder. Methods: A decision-analytic model was constructed to compare costs and quality adjusted life years (QALYs) of 28 interventions for social anxiety disorder from the perspective of the British National Health Service and personal social services. Efficacy data were derived from a systematic review and network meta-analysis. Other model input parameters were based on published literature and national sources, supplemented by expert opinion. Results: Individual cognitive therapy was the most cost-effective intervention for adults with social anxiety disorder, followed by generic individual cognitive behavioural therapy (CBT), phenelzine and book-based self-help without support. Other drugs, group-based psychological interventions and other individually delivered psychological interventions were less cost-effective. Results were influenced by limited evidence suggesting superiority of psychological interventions over drugs in retaining long-term effects. The analysis did not take into account side effects of drugs. Conclusion: Various forms of individually delivered CBT appear to be the most cost-effective options for the treatment of adults with social anxiety disorder. Consideration of side effects of drugs would only strengthen this conclusion, as it would improve even further the cost effectiveness of individually delivered CBT relative to phenelzine, which was the next most cost-effective option, due to the serious side effects associated with phenelzine. Further research needs to determine more accurately the long-term comparative benefits and harms of psychological and pharmacological interventions for social anxiety disorder and establish their relative cost effectiveness with greater certainty.
AB - Background: Social anxiety disorder is one of the most persistent and common anxiety disorders. Individually delivered psychological therapies are the most effective treatment options for adults with social anxiety disorder, but they are associated with high intervention costs. Therefore, the objective of this study was to assess the relative cost effectiveness of a variety of psychological and pharmacological interventions for adults with social anxiety disorder. Methods: A decision-analytic model was constructed to compare costs and quality adjusted life years (QALYs) of 28 interventions for social anxiety disorder from the perspective of the British National Health Service and personal social services. Efficacy data were derived from a systematic review and network meta-analysis. Other model input parameters were based on published literature and national sources, supplemented by expert opinion. Results: Individual cognitive therapy was the most cost-effective intervention for adults with social anxiety disorder, followed by generic individual cognitive behavioural therapy (CBT), phenelzine and book-based self-help without support. Other drugs, group-based psychological interventions and other individually delivered psychological interventions were less cost-effective. Results were influenced by limited evidence suggesting superiority of psychological interventions over drugs in retaining long-term effects. The analysis did not take into account side effects of drugs. Conclusion: Various forms of individually delivered CBT appear to be the most cost-effective options for the treatment of adults with social anxiety disorder. Consideration of side effects of drugs would only strengthen this conclusion, as it would improve even further the cost effectiveness of individually delivered CBT relative to phenelzine, which was the next most cost-effective option, due to the serious side effects associated with phenelzine. Further research needs to determine more accurately the long-term comparative benefits and harms of psychological and pharmacological interventions for social anxiety disorder and establish their relative cost effectiveness with greater certainty.
UR - http://www.scopus.com/inward/record.url?scp=84949579967&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84949579967&partnerID=8YFLogxK
U2 - 10.1371/journal.pone.0140704
DO - 10.1371/journal.pone.0140704
M3 - Article
C2 - 26506554
AN - SCOPUS:84949579967
SN - 1932-6203
VL - 10
JO - PloS one
JF - PloS one
IS - 10
M1 - e0140704
ER -